Aplastic anemia complicating eosinophilic fasciitis: a literature review
Beyond Rheumatology 2023;
5
(3)
: e489
DOI: 10.53238/br_202312_489
Topic: Autoimmune rheumatic diseases
Category: Review
Abstract
Objective: Eosinophilic fasciitis (EF) is an uncommon rheumatological disorder that may complicate with aplastic anemia (AA). We aimed at reviewing the literature on AA associated with EF.
Materials and Methods: Published articles were selected using the following entry terms: "eosinophilic fasciitis", “Shulman’s disease” and “aplastic anemia”. All-important data were collected.
Results: Case descriptions on 16 patients were reported. Age varied from 18 to 62 years, most males and AA appeared, in general, within the first year after EF diagnosis. In three patients, rituximab was used, and bone marrow transplantation was done in 4 of them. Paroxysmal nocturnal hemoglobinuria (PNH) clone was searched in 6 of the reviewed patients and was positive in 2.
Conclusions: AA in EF showed a predominance of older males; most of them developed AA within 12 months after EF diagnosis and treatment included glucocorticoid, ATG and immune suppressive drugs, bone marrow transplantation and rituximab.
To cite this article
Aplastic anemia complicating eosinophilic fasciitis: a literature review
Beyond Rheumatology 2023;
5
(3)
: e489
DOI: 10.53238/br_202312_489
Publication History
Submission date: 10 Nov 2022
Revised on: 17 Jan 2023
Accepted on: 02 Mar 2023
Published online: 22 Dec 2023
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.